Trilogy Capital’s Allergan plc AGN Stock Holding History

Trilogy Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17	Closed	-$3K	–	631
2018 Q3	$3K	Hold	17	–	–	﹤0.01%	478
2018 Q2	$3K	Hold	17	–	–	﹤0.01%	439
2018 Q1	$3K	Buy	+17	New	+$2.85K	﹤0.01%	369

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Trilogy Capital's AGN Position: Q4 2018 in Review

Trilogy Capital sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 17 shares — an estimated $3K sold.

Trilogy Capital first reported a position in AGN in Q1 2018 and held it in 3 quarters. The position peaked at $3K in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

Trilogy Capital reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 17 Allergan plc shares in Q4 2018, an estimated $3K.
Trilogy Capital first reported a position in Allergan plc in Q1 2018 and held it in 3 quarters.
Trilogy Capital's Allergan plc position peaked at $3K in Q3 2018.
1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.